News Focus
News Focus
Replies to #6899 on Biotech Values
icon url

DewDiligence

04/05/05 10:27 AM

#9680 RE: DewDiligence #6899

PFE has four anti-angio compounds in early development for eye disease: three of its own compounds and one acquired from Angiosyn (#msg-5169089). This is in addition to PFE’s participation in Macugen.

Source: PFE webcast in progress.